First Eagle U.S. Fund BIO Holdings History
First Eagle U.S. Fund's Bio-Rad Laboratories Inc Holding Summary
As of 2025-04-30, First Eagle U.S. Fund held 50,797.00 shares of Bio-Rad Laboratories Inc(BIO), totaling $12.40 Mil. This investment constitutes 1.2% of their stock portfolio, and First Eagle U.S. Fund now holds 0.19% of the outstanding Bio-Rad Laboratories Inc(BIO) stock.
The initial trade took place in 2024Q3. And since then First Eagle U.S. Fund has made 2 purchases of BIO, at an average price of $275.20, for a total of 50,797.00 shares. Based on historical transaction data and BIO's current price of $251.56, First Eagle U.S. Fund's estimated gain on his BIO holdings is $-1.20 Mil, reflecting a -8.59% gain to date.
First Eagle U.S. Fund BIO ($251.56) Holding Chart
First Eagle U.S. Fund BIO ($251.56) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
